Delivery Order SPE2DB20D7059-SPE2DB25FQNW2
- Not listed
- The Defense Logistics Agency awarded a $1,071.66 delivery order to AmerisourceBergen Drug Corp for Junel FE 1 mg-20 mcg tablets (28-count) on July 18, 2025, with completion scheduled for July 21, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a single transaction under AmerisourceBergen's broader contract vehicle with DLA....
- The Defense Logistics Agency awarded a delivery order valued at $2,623.20 to AmerisourceBergen Drug Corp for the supply of Junel FE 1 mg-20 mcg tablets (28-count packages). This non-set-aside, competitively awarded contract utilizes firm fixed price pricing and has an ultimate completion date of August 25, 2025. The delivery order was issued on August 22, 2025, with performance occurring at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order valued at $2,587.38 to AmerisourceBergen Drug Corp for the supply of Junel FE 1 mg-20 mcg tablets (28-count packages) on August 11, 2025. This firm fixed-price, non-set-aside contract is scheduled for completion by August 12, 2025, with performance at the vendor's facility in Conshohocken, Pennsylvania. The delivery order represents a single transaction under AmerisourceBergen's broader relationship with the federal government for...
- The Defense Logistics Agency awarded a delivery order valued at $1,402.75 to AmerisourceBergen Drug Corp for Junel Fe 1 mg-20 mcg tablets (28-count packaging) on July 30, 2025, with completion scheduled for July 31, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract represents a single transaction within AmerisourceBergen Drug Corp's...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $6,558.38 to AmerisourceBergen Drug Corp for the supply of Junel Fe 1 mg-20 mcg tablets (28-count) on September 8, 2025, with an ultimate completion date of September 9, 2025. This non-set-aside, competitively awarded contract employs firm fixed price pricing and represents a child delivery order issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The...
- The Defense Logistics Agency awarded a $1,650.55 firm fixed price delivery order to AmerisourceBergen Drug Corp for Junel FE 1 mg-20 mcg tablets (28-count packaging) on September 16, 2025, with completion scheduled for September 17, 2025. This non-set-aside contract represents a delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The product will be performed at...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Junel FE 1 mg-20 mcg tablets (28-count packaging) under a firm fixed-price contract valued at $1,576.29. The award, issued on July 30, 2025, with an ultimate completion date of July 31, 2025, represents a non-competitive delivery order placed against AmerisourceBergen's existing indefinite delivery vehicle. Performance will be executed from the contractor's facility in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order valued at $3,570.36 to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Junel FE 1.5 mg-30 mcg tablets (28-count packages). This firm fixed price, non-set-aside delivery order is scheduled for completion by August 20, 2025, with performance occurring at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider,...
- The Defense Logistics Agency awarded a delivery order valued at $1,011.54 to AmerisourceBergen Drug Corp for the supply of Junel FE 1.5 mg-30 mcg tablets in a 28-count package. This competitively awarded, firm fixed-price contract was issued on July 31, 2025, with an ultimate completion date of August 1, 2025. The contractor will perform work at its corporate office location in Conshohocken, Pennsylvania. This delivery order represents a routine pharmaceutical procurement supporting federal...
- The Defense Logistics Agency awarded a delivery order valued at $1,810.99 to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Junel FE 1 mg-20 mcg tablets in a 28-count package. This is a firm fixed price delivery order with no set-aside designation, competitively awarded under open competition. The contract calls for performance completion by September 19, 2025, with the product to be delivered to or performed at AmerisourceBergen's corporate office location in Conshohocken,...
- SPE2DB20D7059Indefinite Delivery Contract
- SPE2DB20D7059-SPE2DB25FQNW2Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,904.40 to AmerisourceBergen Drug Corp for Junel FE 1 mg–20 mcg tablets (28-count packages) on August 21, 2025, with an ultimate completion date of August 22, 2025. This firm fixed-price, competitively awarded delivery order represents a non-set-aside procurement executed through AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The pharmaceutical distributor, headquartered in Conshohocken, Pennsylvania, will fulfill this order at its corporate office location, which also serves as the place of performance. This delivery order is a child contract under AmerisourceBergen's substantial $999.999 billion IDC with DLA Troop Support Medical, which extends through December 2026 and functions as a comprehensive global pharmaceutical support vehicle. The IDC enables AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including specialty medications, brand-name and generic drugs, and medical devices. AmerisourceBergen's substantial federal contract portfolio and proven capability to meet federal medical procurement requirements through open competition position it as a critical vendor for the Defense Health Agency and other military healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.9k | 8/21/25 |